Alteration of glial fibrillary acidic proteins immunoreactivity in astrocytes of the spinal cord diabetic rats

Anatomical Record

Volumn 291, Issue 4, 2008, Pages 390-399

  Afsari, Zainab H ^a   Renno, Waleed M ^a   Adb El Basset, E ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

CNS; Diabetes; Glial fibrillary acidic protein; Immunohistochemistry; Intermediate filament; Neuropathy; Spinal cord

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN;

ANIMAL; ARTICLE; ASTROCYTE; CYTOLOGY; EXPERIMENTAL DIABETES MELLITUS; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; RAT; SPINAL CORD; SPRAGUE DAWLEY RAT; TIME; TISSUE DISTRIBUTION;

ANIMALS; ASTROCYTES; DIABETES MELLITUS, EXPERIMENTAL; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 42949114864     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.20678     Document Type: Article

References (46)

1. Abbott NJ. 2002. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 200:629-638.
2. Abd-El-Basset EM, Kalnins VI, Ahmed I, Fedoroff S. 1989. A 48 kilodalton intermediate filament associated protein (IFAP) in reactive- like astrocytes induced by dibutyrel cyclic AMP in culture and in reactive astrocytes in situ. J Neuropathol Exp Neuol 48: 245-254.
3. Abu El-Asrar AM, Meersschaert A, Dralands L, Missotten L, Geboes K. 2004. Inducible nitric oxide synthase and vascular endothelial growth factor are colocalized in the retinas of human subjects with diabetes. Eye 18:306-313.
4. Aizenman Y, Weichsel ME Jr, de Vellis J. 1989. Changes in insulin and transferrin requirements of pure brain neuronal cultures during embryonic development. Proc Natl Acad Sci U S A 83: 2263-2266.
5. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M. 2003. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 52:506-511.
6. Barber AJ, Antonetti DA, Gardner TW. 2000. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. Invest Ophthalmol Vis Sci 41:3561-3568.
7. Baydas G, Nedzvetskii VS, Tuzcu M, Yasar A, Kirichenko SV. 2003a. Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur J Pharmacol 462:67-71.
8. Baydas G, Retter RJ, Yaser A, Tuzcu M, Akdemir I, Nedzvetskii V. 2003b. Melatonin reduces glial reactivity in the hippocampus, cortex and cerebellum of streptozotocin-in diabetic rats. Free Radic Biol Med 35:797-804.
9. Bignami A, Dahl D. 1977. Specificity of the glial fibrillary acidic protein for astroglia. J Histochem Cytochem 25:466-469.
10. Brenner M, Johnson AB, Boesflug-Tanguy O, Rodriguez D, Goldman JE, Messing A. 2001. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 27:117-120.
11. Cam MC, Rodrigues B, McNeill JH. 1999. Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes. Eur J Endocrinol 141:546-554.
12. Coleman E, Judd R, Hoe L, Dennis J, Posner P. 2004. Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 48:166-178.
13. Dennis JC, Coleman ES, Swyers SE, Moody SW, Wright JC, Judd R, Zhong Q, Morrison EE. 2005. Changes in mitotic rate and GFAP expression in the primary olfactory axis of streptozotocin-induced diabetic rats. J Neurocytol 34:3-10.
14. Eng LF, Ghirnikar RS, Lee YL. 2000. Glial fibrillary acidic protein: GFAP-thirty one years (1969-2000). Neurochem Res 25:1439-1451.
15. Eng LF, Yandrhaegan JJ, Bignami A, Gerstle B. 1971. An acidic protein isolated from fibrous astrocytes. Brain Res 28:351-354.
16. Goodison KL, Parhad IM, White CL III, Sima AA, Clark AW. 1993. Neuronal and glial gene expression in neocortex of Down's syndrome and Alzheimer's disease. J Neuropathol Exp Neurol 52:192-198.
17. Horani MH, Mooradian AD. 2003. Effect of diabetes on the blood brain barrier. Curr Pharm Des 9:833-840.
18. Junqueira LC, Carneiro J. 2003. Basic histology, text and atlas. 10th ed. New York: McGraw-Hill.
19. Lamigeon C, Bellier JP, Sacchettoni S, Rujano M, Jacquemont B. 2001. Enhanced neuronal protection from oxidative stress by coculture with glutamic acid decarboxylase-expressing astrocytes. J Neurochem 77:598-606.
20. Liedtke W, Edelmann W, Bieri PL, Chiu FC, Cowan NJ, Kucherlapati R, Raine CS. 1996. GFAP is necessary for the integrity of CNX white matter architecture and long-term maintenance of myelination. Neuron 17:607-615.
21. Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D, Strother JM. 1998. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes 47:815-820.
22. Louw DF, Masada T, Sutherland GR. 1998. Ischemic neuronal injury is ameliorated by astrocyte activation. Can J Neurol Sci 25:102-107.
23. Magistretti PJ, Pellerin L. 1999. Astrocytes couple synaptic activity to glucose utilization in the brain. News Physiol Sci 14:177-182.
24. Mankovsky BN, Metzger BE, Molitch ME, Biller J. 1996. Cerebrovascular disorders in patients with diabetes mellitus. J Diabetes Complications 10:228-242.
25. McCall MA, Gregg RG, Behringer RR, Brenner M, Delaney CL, Galbreath EJ, Zhang CL, Pearce RA, Chiu SY, Messing A. 1996. Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc Natl Acad Sci U S A 93:6361-6366.
26. Mendonca JE, Vilela MC, Bittencourt H, Lapa RM, Oliveira FG, Alessio ML, Guedes RC, De Oliveira Costa MS, Da Costa BL. 2004. GFAP expression in astrocytes of suprachiasmatic nucleus and medial preoptic area are differentially affected by malnutrition during rat brain development. Nutr Neurosci 7:223-234.
27. Menet V, Gimenez Y, Ribotta M, Chauvet N, Drian MJ, Lannoy J, Golucci-Guyon E, Privat A. 2001. Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression. J Neurosci 21:6147-6158.
28. Mizutani M, Gerhardinger C, Lorenzi M. 1998. Muller cell changes in human diabetic retinopathy. Diabetes 47:445-449.
29. Montgomery DL. 1994. Astrocytes: form, functions, and roles in disease. Vet Pathol 31:145-167.
30. Morrison RS, De Vellis J, Lee YL, Bradshaw RA, Eng LF. 1985. Hormones and growth factors induce the synthesis of glial fibrillary acidic protein in rat brain astrocytes. J Neurosci Res 14:167-176.
31. Nicoles NR, Day JR, Laping NJ, Johnson SA, Finch CE. 1993. GFAP mRNA increases with age in rat and human brain. Neurobiol Aging 14:421-429.
32. Norton WT, Aquino DA Hozumi I, Chiu FC, Brosnan CF. 1992. Quantitative aspects of reactive gliosis. Neurochem Res 17:877-885.
33. Rakieten N, Rakieten ML, Moreshwar VN. 1963. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 29:91-98.
34. Reagan LP, Magarinos AM, Lucas LR, van Bueren A, McCall AL, McEwen BS. 1999. Regulation of GLUT-3 glucose transporter in the hippocampus of diabetic rats subjected to stress. Am J Physiol 276:E879-E886.
35. Reagan LP, Magarinos AM, Yee DK, Swzeda LI, Van Bueren A, McCall AL, McEwen BS. 2000. Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress. Brain Res 862:292-300.
36. Reier PJ, Houle JD. 1988. The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair. Adv Neurol 47:87-138.
37. Renno WM, Saleh F, Klepacek I, Al-Awadi F. 2006. Talin immunogold density increases in sciatic nerve of diabetic rats after nerve growth factor treatment. Medicina (Kaunas) 42:147-163.
38. Rungger-Brandle E, Dosso AA, Leuenberger PM. 2000. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 41:1971-1980.
39. Saravia FE, Revsin Y, Gonzalez Deniselle MC, Gonzalez SL, Roig P, Lima A, Homo-Delarche F, De Nicola AF. 2002. Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice. Brain Res 957:345-353.
40. Singh DNP, Mathew TC. 1989. Immunocytochemical studies of astrocytes following injury to the cerebral cortex of the rat. Acta Anat 134:156-159.
41. Stuesse SL, Crisp T, McBurney DL, Schechter JB, Lovell JA, Cruce WL. 2001. Neuropathic pain in aged rats: behavioral responses and astrocytic activation. Exp Brain Res 137:219-227.
42. Takamiya Y, Kohsaka S, Toya S, Otani M, Tsukada Y. 1988. Immunohistochemical studies on the proliferation of reactive astrocytes and the expression of cytoskeletal proteins following brain injury in rats. Brain Res 466:201-210.
43. Tanihara H, Hangai M, Sawaguchi S, Abe H, Kageyama M, Nakazawa F, Shirasawa E, Honda Y. 1997. Up-regulation of glial fibrillary acidic protein in the retina of primate eyes with experimental glaucoma. Arch Ophthalmol 115:752-756.
44. Toran-Allerand CD, Bentham W, Miranda RC, Anderson JP. 1991. Insulin influences astroglial morphology and glial fibrillary acidic protein (GFAP) expression in organotypic cultures. Brain Res 558:296-304.
45. Weinstein DE, Shelanski ML, Liem RK. 1991. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol 112:1205-1213.
46. Zeng XX, Ng YK, Ling EA. 2000. Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci 17:463-471.